Tech Company Financing Transactions

Galleon Pharmaceuticals Funding Round

Galleon Pharmaceuticals closed a $1.5 million funding round on 11/22/2013. Investors included private investors.

Transaction Overview

Announced On
11/22/2013
Transaction Type
Debt
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment solicitation details, if applicable.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3701 Market St. 5th Floor
Philadelphia, PA 19044
USA
Email Address
Overview
Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.
Profile
Galleon Pharmaceuticals LinkedIn Company Profile
Social Media
Galleon Pharmaceuticals Company Twitter Account
Company News
Galleon Pharmaceuticals News
Facebook
Galleon Pharmaceuticals on Facebook
YouTube
Galleon Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joseph Oliveto
  Joseph Oliveto LinkedIn Profile  Joseph Oliveto Twitter Account  Joseph Oliveto News  Joseph Oliveto on Facebook
Chief Medical Officer
James McLeod
  James McLeod LinkedIn Profile  James McLeod Twitter Account  James McLeod News  James McLeod on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/22/2013: HiringSolved venture capital transaction
Next: 11/23/2013: The Hunt venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary